{
    "2020-01-02": [
        [
            {
                "time": "2019-07-15",
                "original_text": "Johnson & Johnson sued by Washington state over opioid crisis",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "sued",
                        "Washington state",
                        "opioid crisis"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-11-26",
                "original_text": "Pulmatrix Shares Soar On Licensing Agreement With Johnson & Johnson",
                "features": {
                    "keywords": [
                        "Pulmatrix",
                        "Shares",
                        "Soar",
                        "Licensing Agreement",
                        "Johnson & Johnson"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-01-14",
                "original_text": "Johnson & Johnson Announces Quarterly Dividend for First Quarter 2020",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "Quarterly Dividend",
                        "First Quarter",
                        "2020"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}